Globuloside B



Compound IDCDAMM01832
Common nameGlobuloside B
IUPAC name[7-(benzoyloxymethyl)-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-5-yl] 7-(hydroxymethyl)-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate
Molecular formulaC38H46O19

Experimental data

Retention time7.35
Adduct[M+H]+
Actual mz807.275
Theoretical mz807.27
Error6.22
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6814

Identifiers and class information

Inchi keyPOILUOKEDPTHIF-ZNEGEFHINA-N
SmilesO=C(OCC1=CC(OC(=O)C2=COC(OC3OC(CO)C(O)C(O)C3O)C4C(=CCC24)CO)C5C=COC(OC6OC(CO)C(O)C(O)C6O)C15)C=7C=CC=CC7
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)15
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)21
Number of reactive functional groups (#rtvFG)6
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)806.77
Computed dipole moment(dipole)5.254
Total solvent accessible surface area (SASA)1074.9
Hydrophobic component of SASA (FOSA)337.342
Hydrophilic component of SASA (FISA)398.414
Pie component of the SASA (PISA)339.148
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2138.82
Number of hydrogen bond donors (donorHB)9
Number of hydrogen bond acceptors (accptHB)29.5
Free energy of solvation of dipole (dip^2/V)0.0129084
Index of cohesive interaction in solids (ACxDN^.5/SA)0.082333
Globularity descriptor (glob)0.74687
Predicted polarizability in cubic angstroms (QPpolrz)69.196
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.531
Predicted octanol/gas partition coefficient (QPlogPoct)53.506
Predicted water/gas partition coefficient (QPlogPw)44.929
Predicted octanol/water partition coefficient (QPlogPo/w)-2.525
Predicted aqueous solubility (QPlogS)-2.337
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.352
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.245
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1.651
Predicted brain/blood partition coefficient (QPlogBB)-5.464
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.486
Predicted skin permeability, log Kp (QPlogKp)-5.651
PM3 calculated ionization potential (IP(ev))9.638
PM3 calculated electron affinity (EA(eV))0.414
Number of likely metabolic reactions (#metab)16
Prediction of binding to human serum albumin (QPlogKhsa)-2.048
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)300.612
Number of nitrogen and oxygen atoms (#NandO)19
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P17931LGALS3Galectin-3T72038SEA
P09382LGALS1Galectin-1T09544SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3

Copyright © 2025